The difference between legal and scientific substitutability
This article was originally published in Scrip
Executive Summary
The tussle between Germany’s research-based pharmaceutical industry and health insurers over discount contracts has taken on a new dimension, questioning the very interchangeability of medicines that contain the same active ingredient.